Several companies, including Odysight.ai, Edesa Biotech, and QNB Corp, have announced public offerings to raise capital. Odysight.ai priced an $11M offering at $3.20 per share, while Edesa Biotech priced a $25M offering at $5.50 per share.

Edesa Biotech has announced it secured $3.5 million in PIPE (Private Investment in Public Equity) financing.

Edesa Biotech (EDSA) has reaffirmed its previously announced timeline for a clinical study on a vitiligo treatment, expected to commence in 2026.